Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
US Army
Argus Health

Generated: June 26, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018082

Try a free trialSee Plans and Pricing

« Back to Dashboard

NDA 018082 describes DEPAKENE, which is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. Additional details are available on the DEPAKENE profile page.

The generic ingredient in DEPAKENE is valproic acid. There are seventeen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the valproic acid profile page.
Summary for 018082
Ingredient:valproic acid
Formulation / Manufacturing:see details
Pharmacology for NDA: 018082
Medical Subject Heading (MeSH) Categories for 018082
Suppliers and Packaging for NDA: 018082
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEPAKENE valproic acid SYRUP;ORAL 018082 NDA AbbVie Inc. 0074-5682 0074-5682-16 473 mL in 1 BOTTLE (0074-5682-16)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength250MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.